Kiniksa Pharmaceuticals Stock Widgets and Gadgets
KNSA Stock | USD 18.54 0.15 0.82% |
Intraday Equity Chart Quick Equity Feed Equity Search Quote Ticker Widgets Data Sheet |
Live Stock Ticker Example
- KNSA Kiniksa Pharmaceuticals
- Latest JPMorgan Chase Co. Takes 5 Million Position in Kiniksa Pharmaceuticals, Ltd. - MarketBeat
- KNSA 18.54 0.15
- Low 18.27
- High 18.74
- Alpha -0.52
- Beta 0.34
- Return On Equity -0.0215
- Return On Asset -0.0316
- Profit Margin (0.02) %
- Operating Margin (0.09) %
- Current Valuation 1.13 B
- Shares Outstanding 41.57 M
- Shares Owned By Insiders 4.10 %
- Shares Owned By Institutions 98.02 %
- Number Of Shares Shorted 3.39 M
- Price To Earning (7.20) X
- Price To Book 3.06 X
- Price To Sales 3.49 X
- Revenue 270.26 M
- Gross Profit 234.44 M
- EBITDA (22.86 M)
- Net Income 14.08 M
- Cash And Equivalents 138.21 M
- Cash Per Share 1.99 X
- Total Debt 12.26 M
- Debt To Equity 0.03 %
- Current Ratio 4.13 X
- Book Value Per Share 6.06 X
- Cash Flow From Operations 13.3 M
- Short Ratio 9.47 X
- Earnings Per Share (0.12) X
- Price To Earnings To Growth 0.25 X
- Target Price 36.0
- Number Of Employees 297
- Beta 0.35
- Market Capitalization 1.34 B
- Total Asset 526.32 M
- Retained Earnings (477.95 M)
- Working Capital 212.63 M
- Current Asset 54.44 M
- Current Liabilities 10.39 M
- Net Asset 526.32 M
- Accumulation Distribution 0.0251
- Daily Balance Of Power 0.3191
- Rate Of Daily Change 1.01
- Day Median Price 18.51
- Day Typical Price 18.52
- Market Facilitation Index 0.47
- Price Action Indicator 0.11
- Period Momentum Indicator 0.15
Market Snapshot Widget Example
DAX Index Germany | 20,990 0.42 | |
Taiwan Weighted Taiwan | 23,267 0.51 | |
PSI 20 Stock Portugal | 6,584 0.31 | |
CROBEX Croatia | 3,384 0.51 | |
Budapest SE Hungary | 85,903 1.21 | |
IDX 30 Jakarta Indonesia | 429.63 0.24 | |
ISEQ 20 Price Ireland | 1,647 0.92 | |
NYSE Comp USA | 19,607 0.30 | |
Tel Aviv 35 Israel | 2,552 1.04 | |
Coreshares Index Tracker South Afric | 1,132 1.16 | |
IPC MEXICO Mexico | 50,269 0.68 | |
KL Technology Malaysia | 61.29 0.91 | |
IBEX 35 Index Spain | 11,944 0.23 | |
SP Merval Argentina | 1,000,000 0.00 | |
Austrian Traded Index Austria | 3,801 0.55 | |
SPASX Dividend Opportunities Australia | 1,692 0.50 | |
HNX 30 Vietnam | 460.25 0.42 | |
Bucharest BET-NG Romania | 1,227 0.12 | |
AMS Small Cap Netherlands | 1,266 0.58 | |
Oslo Exchange Mutual Norway | 1,444 0.07 | |
BEL Small Belgium | 8,555 0.44 | |
Basic Materials Brazil | 5,445 0.52 | |
Swiss Leader Price Switzerland | 1,994 0.42 | |
Fondo Mutuo ETF Chile | 1,458 0.54 | |
Athens General Comp Greece | 1,531 0.41 | |
Stock Exchange Of Thailand | 1,340 0.0097 | |
PX Prague Stock Czech Repub | 1,839 1.49 | |
THE PHILIPPINE STOCK Philippines | 6,350 0.04 | |
WIG 30 Poland | 2,970 0.77 | |
BIST Electricity Turkey | 516.13 0.41 |
Investing Ideas
In addition to having Kiniksa Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Compare Kiniksa Pharmaceuticals
Compare Kiniksa Pharmaceuticals To Peers
Complementary Tools for Kiniksa Stock analysis
When running Kiniksa Pharmaceuticals' price analysis, check to measure Kiniksa Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kiniksa Pharmaceuticals is operating at the current time. Most of Kiniksa Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Kiniksa Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kiniksa Pharmaceuticals' price. Additionally, you may evaluate how the addition of Kiniksa Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |